- Home
- BBLG vs QNRX Comparison
BBLG vs QNRX Comparison
Compare BBLG & QNRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BBLG
- QNRX
- Stock Information
- Founded
- BBLG 2004
- QNRX 2018
- Country
- BBLG United States
- QNRX United States
- Employees
- BBLG N/A
- QNRX N/A
- Industry
- BBLG Industrial Specialties
- QNRX Medical/Dental Instruments
- Sector
- BBLG Health Care
- QNRX Health Care
- Exchange
- BBLG Nasdaq
- QNRX Nasdaq
- Market Cap
- BBLG 2.8M
- QNRX 2.5M
- IPO Year
- BBLG N/A
- QNRX N/A
- Fundamental
- Price
- BBLG $0.84
- QNRX $0.29
- Analyst Decision
- BBLG
- QNRX
- Analyst Count
- BBLG 0
- QNRX 0
- Target Price
- BBLG N/A
- QNRX N/A
- AVG Volume (30 Days)
- BBLG 39.6K
- QNRX 10.6M
- Earning Date
- BBLG 05-13-2025
- QNRX 03-13-2025
- Dividend Yield
- BBLG N/A
- QNRX N/A
- EPS Growth
- BBLG N/A
- QNRX N/A
- EPS
- BBLG N/A
- QNRX N/A
- Revenue
- BBLG N/A
- QNRX N/A
- Revenue This Year
- BBLG N/A
- QNRX N/A
- Revenue Next Year
- BBLG N/A
- QNRX N/A
- P/E Ratio
- BBLG N/A
- QNRX N/A
- Revenue Growth
- BBLG N/A
- QNRX N/A
- 52 Week Low
- BBLG $0.71
- QNRX $0.21
- 52 Week High
- BBLG $4.25
- QNRX $1.57
- Technical
- Relative Strength Index (RSI)
- BBLG 45.78
- QNRX 49.51
- Support Level
- BBLG $0.79
- QNRX $0.21
- Resistance Level
- BBLG $0.87
- QNRX $0.32
- Average True Range (ATR)
- BBLG 0.05
- QNRX 0.03
- MACD
- BBLG 0.01
- QNRX -0.00
- Stochastic Oscillator
- BBLG 49.00
- QNRX 38.70
About BBLG Bone Biologics Corp
Bone Biologics Corp is a healthcare solutions provider based in the United States. As a biotechnology firm, it engages its efforts in developing therapeutics to aid bone regeneration. The company's portfolio comprises its lead product, NELL-1, which is a bone void filler. Bone Biologics' technology has applications in the surgical specialties of spinal, orthopedic, general orthopedic, plastic reconstruction, neurosurgery, interventional radiology, and sports medicine.
About QNRX Quoin Pharmaceuticals Ltd.
Quoin Pharmaceuticals Ltd is a clinical stage specialty pharmaceutical company focused on developing and commercializing therapeutic products that treat rare and orphan diseases. Its pipeline comprises three products that collectively have the potential to target a broad number of rare and orphan indications, including Netherton Syndrome, Peeling Skin Syndrome, Palmoplantar Keratoderma, Epidermolysis Bullosa, and others.